|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
1989-10-20
|
|
pubmed:abstractText |
Thirty nine patients with polymyalgia rheumatica (PMR) and 35 with giant cell arteritis (GCA) were treated with high or low dose steroid regimens in a prospective study of the first two months of treatment. Patients with PMR needed 15-20 mg prednisolone initially; 13/20 (65%) relapsed on an initial dose of 10 mg/day. All but two patients with GCA were successfully treated with 40 mg/day prednisolone initially but relapsed on a reduction to 20 mg/day. One patient with GCA receiving 30 mg/day relapsed after four weeks. Six patients with PMR developed GCA during the first two months and required an increased prednisolone dose to control symptoms. The erythrocyte sedimentation rate or C reactive protein did not predict relapse.
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/2782975-1198014,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2782975-14189726,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2782975-2383089,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2782975-2782976,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2782975-327947,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2782975-389046,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2782975-4036982,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2782975-4117268,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2782975-4644163,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2782975-493941,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2782975-5101106,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2782975-5850337,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2782975-6116280,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2782975-6220355,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2782975-6779980,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2782975-6882032,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2782975-6982645,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2782975-6992550,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2782975-7246269,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2782975-7469518,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2782975-848358,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2782975-96334
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
0003-4967
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
48
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
658-61
|
|
pubmed:dateRevised |
2009-11-18
|
|
pubmed:meshHeading |
|
|
pubmed:year |
1989
|
|
pubmed:articleTitle |
Treatment of polymyalgia rheumatica and giant cell arteritis. I. Steroid regimens in the first two months.
|
|
pubmed:affiliation |
Rheumatology Research Unit, Addenbrooke's Hospital, Cambridge.
|
|
pubmed:publicationType |
Journal Article
|
